The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Distant recurrence–free survival in invasive lobular carcinoma (ILC) with isolated tumor cells: Does pN0(i+) behave like node-negative or node-positive disease?
 
Jason Mouabbi
Employment - MD Anderson Cancer Center
Honoraria - BostonGene
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Gilead Sciences; Novartis
Research Funding - Bristol Myers Squibb Foundation (Inst); Summit pharmaceuticals (Inst)
(OPTIONAL) Uncompensated Relationships - Lobular Breast Cancer Alliance
 
Akshara Singareeka Raghavendra
No Relationships to Disclose
 
Taiwo Adesoye
Consulting or Advisory Role - Boehringer labs
 
Sarah Pasyar
No Relationships to Disclose
 
Roland Bassett
No Relationships to Disclose
 
Rita Mukhtar
Research Funding - GE Healthcare
Patents, Royalties, Other Intellectual Property - Patent on the use of fibrin and silver microparticles to promote wound healing. (I)
 
Vicente Valero
Honoraria - AstraZeneca; Exact Sciences
Consulting or Advisory Role - AstraZeneca; Beijing Saint Lucia Hospital Management Consulting Company; Gilead Sciences; Stemline Therapeutics
Travel, Accommodations, Expenses - Genentech/Roche
 
Amy Hassan
No Relationships to Disclose
 
Azadeh Nasrazadani
No Relationships to Disclose
 
Bora Lim
Honoraria - Department of Defense; SABCS
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Natera; Novartis; Pfizer
Research Funding - Calithera Biosciences; Genentech; Incyte; Merck; Puma Biotechnology; Takeda
 
Richard Ehlers
No Relationships to Disclose
 
Cristina Checka
No Relationships to Disclose
 
Rachel Layman
Honoraria - Pfizer
Consulting or Advisory Role - BioTheryX; Boundless Bio; Celcuity; Gilead Sciences; Lilly; Novartis
Research Funding - Accutar Biotech (Inst); Arvinas (Inst); BioTheryX (Inst); Celcuity (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Zentalis (Inst)
(OPTIONAL) Uncompensated Relationships - Celcuity; Lilly
 
Mariana Chavez Mac Gregor
Employment - MD Anderson Physician’s Network
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca/Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; Merck; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca; Genentech/Roche (Inst); Lilly; Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Exact Sciences; Gilead Sciences; Novartis; Pfizer; Zodiac Pharma
(OPTIONAL) Uncompensated Relationships - The Hope Foundation
 
Sharon Giordano
No Relationships to Disclose
 
Jennifer Litton
Honoraria - UpToDate
Patents, Royalties, Other Intellectual Property - Patent Royalty by Certis (Inst); UptoDate
(OPTIONAL) Uncompensated Relationships - Gilead Sciences
 
Funda Meric-Bernstam
Employment - MD Anderson Cancer Center
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca; Becton Dickinson; Biocartis; Calibr; Cybrexa Therapeutics; Daiichi Sankyo/Astra Zeneca; DAVA Pharmaceuticals; Debiopharm Group; eFFECTOR Therapeutics; Elevation Oncology; Exelixis; Go Therapeutics; GT Aperion; Guardant Health; Harbinger Health; Illumen; Incyte; Jazz Pharmaceuticals; Kivu Biosciences; Lengo Therapeutics; LigaChem Biosciences; Loxo/Lilly; Menarini Group; Mersana; Molecular Templates; OnCusp Therapeutics; Protai; Ribometrix; Sanofi; Seagen; SystImmune; Tallac Therapeutics; Tempus; Theratechnologies; Vir Biotechnology; Zentalis; Zymeworks
Research Funding - Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Calithera Biosciences (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); eFFECTOR Therapeutics (Inst); Genentech (Inst); Guardant Health (Inst); Jazz Pharmaceuticals (Inst); Klus Pharma (Inst); Novartis (Inst); PUMA Biotechnology (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Cholangiocarcinoma Foundation; Dava Oncology; ESMO; European Organisation for Research and Treatment of Cancer (EORTC); Physicans' Education Resource
 
Henry Kuerer
No Relationships to Disclose